A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Joshua J. Solomon, Robert W. Hallowell, Cecilia Ganslandt, Jessica G. Shull, Thomas Bengtsson, Jakob Ganslandt, Maureen R. Horton |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease (PuRe Duration Trial): A randomized controlled equivalence trial
por: Joshua A. Bishop, et al.
Publicado: (2024)
por: Joshua A. Bishop, et al.
Publicado: (2024)
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
por: John A. Mackintosh, et al.
Publicado: (2024)
por: John A. Mackintosh, et al.
Publicado: (2024)
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial
por: Amy Ying Yu Tsui, et al.
Publicado: (2024)
por: Amy Ying Yu Tsui, et al.
Publicado: (2024)
Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema
por: Marieke C. van der Molen, et al.
Publicado: (2024)
por: Marieke C. van der Molen, et al.
Publicado: (2024)
Familial pulmonary fibrosis: Defining inherited fibrotic lung disease in the era of clinical genetic testing
por: Joanne L. Dickinson, et al.
Publicado: (2024)
por: Joanne L. Dickinson, et al.
Publicado: (2024)
A double‐blind randomized controlled trial of N‐acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease
por: Wang Chung Kwok, et al.
Publicado: (2024)
por: Wang Chung Kwok, et al.
Publicado: (2024)
The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
por: Yichao Zhao, et al.
Publicado: (2024)
por: Yichao Zhao, et al.
Publicado: (2024)
Using change in 6‐minute walk distance to predict survival in progressive pulmonary fibrosis: A promising measure in need of precision
por: Anne E. Holland, et al.
Publicado: (2024)
por: Anne E. Holland, et al.
Publicado: (2024)
Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
por: Yuichi Nagata, et al.
Publicado: (2024)
por: Yuichi Nagata, et al.
Publicado: (2024)
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort
por: Veronica Marcoux, et al.
Publicado: (2024)
por: Veronica Marcoux, et al.
Publicado: (2024)
Winning the Tour de France with endobronchial valve therapy without pulmonary rehabilitation
por: Charlie Strange, et al.
Publicado: (2024)
por: Charlie Strange, et al.
Publicado: (2024)
Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry
por: Wanying Xia, et al.
Publicado: (2024)
por: Wanying Xia, et al.
Publicado: (2024)
The case of huge simple pulmonary aspergilloma that responded remarkably to drug therapy
por: Makoto Yokota, et al.
Publicado: (2024)
por: Makoto Yokota, et al.
Publicado: (2024)
Epidemiology of supplemental oxygen in patients with pulmonary hypertension
por: Rodrigo Torres‐Castro, et al.
Publicado: (2024)
por: Rodrigo Torres‐Castro, et al.
Publicado: (2024)
Clinical trials and clinical trials networks
por: Ary Serpa Neto, et al.
Publicado: (2024)
por: Ary Serpa Neto, et al.
Publicado: (2024)
Allergic broncho‐pulmonary aspergillosis: Old disease, new frontiers
por: Eve Denton, et al.
Publicado: (2024)
por: Eve Denton, et al.
Publicado: (2024)
Chronic pulmonary Aspergillosis in a patient with poorly controlled diabetes: A case report and literatures review
por: Tzu‐I Chuang, et al.
Publicado: (2024)
por: Tzu‐I Chuang, et al.
Publicado: (2024)
A mediastinum‐tumour‐like pulmonary arteriovenous malformation with association to the pulmonary artery treated with surgical resection
por: Yung‐Chia Huang, et al.
Publicado: (2024)
por: Yung‐Chia Huang, et al.
Publicado: (2024)
Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis
por: Wang Chun Kwok, et al.
Publicado: (2024)
por: Wang Chun Kwok, et al.
Publicado: (2024)
Multiple pulmonary nodules with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and minute pulmonary meningothelial‐like nodules
por: Tsuyoshi Sasada, et al.
Publicado: (2024)
por: Tsuyoshi Sasada, et al.
Publicado: (2024)
CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life
por: Hao Wang, et al.
Publicado: (2025)
por: Hao Wang, et al.
Publicado: (2025)
The challenges facing children with pulmonary tuberculosis—a catastrophe of civil war: Letter from Sudan
por: Omer Osman Babiker, et al.
Publicado: (2024)
por: Omer Osman Babiker, et al.
Publicado: (2024)
Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases
por: Fumihiro Kashizaki, et al.
Publicado: (2024)
por: Fumihiro Kashizaki, et al.
Publicado: (2024)
A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy
por: Rebekah Lamb, et al.
Publicado: (2024)
por: Rebekah Lamb, et al.
Publicado: (2024)
Respiratory teletrials—A call for equitable access to clinical trials for people with respiratory conditions
por: Anne E. Holland, et al.
Publicado: (2024)
por: Anne E. Holland, et al.
Publicado: (2024)
Transforming recruitment to clinical trials in COPD
por: Tanya Patrick, et al.
Publicado: (2024)
por: Tanya Patrick, et al.
Publicado: (2024)
Breaking the spiral: How negative mood can fuel exertional breathlessness in people with chronic obstructive pulmonary disease
por: Amy Pascoe, et al.
Publicado: (2024)
por: Amy Pascoe, et al.
Publicado: (2024)
Massive hemoptysis in pregnancy due to invasive pulmonary aspergillosis with pulmonary tuberculosis co‐infection
por: Nurul Aisyah Abd Rahman, et al.
Publicado: (2024)
por: Nurul Aisyah Abd Rahman, et al.
Publicado: (2024)
Acute pulmonary thromboembolism with high‐density emboli in the pulmonary artery detected on non‐enhanced computed tomography
por: Shimpei Kajie, et al.
Publicado: (2024)
por: Shimpei Kajie, et al.
Publicado: (2024)
A case of pulmonary primary MALT lymphoma with distinctive bronchoscopic findings
por: Hiroyuki Miura, et al.
Publicado: (2024)
por: Hiroyuki Miura, et al.
Publicado: (2024)
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
por: Kavya Koshy, et al.
Publicado: (2024)
por: Kavya Koshy, et al.
Publicado: (2024)
Bevacizumab‐induced pulmonary cystic disease
por: Dakota McNierney, et al.
Publicado: (2024)
por: Dakota McNierney, et al.
Publicado: (2024)
Parallel imports of pharmaceutical products in the Eurpean Union / Mattias Ganslandt, Keith E. Maskus
por: Ganslandt, Mattias
Publicado: (2001)
por: Ganslandt, Mattias
Publicado: (2001)
Oxygen therapy could improve survival in patients with early desaturation in the 6‐minute walk test: A post hoc analysis
por: Ignacio García‐Talavera, et al.
Publicado: (2024)
por: Ignacio García‐Talavera, et al.
Publicado: (2024)
Computed tomography mucus plugs and airway tree structure in patients with chronic obstructive pulmonary disease: Associations with airflow limitation, health‐related independence and mortality
por: Naoya Tanabe, et al.
Publicado: (2024)
por: Naoya Tanabe, et al.
Publicado: (2024)
A rare case of allergic bronchopulmonary mycosis complicating pulmonary pleomorphic carcinoma
por: Yoshihiro Okada, et al.
Publicado: (2024)
por: Yoshihiro Okada, et al.
Publicado: (2024)
A case of treatment for pulmonary infection caused by multidrug‐resistant Acinetobacter baumannii
por: Chenxia Guo, et al.
Publicado: (2024)
por: Chenxia Guo, et al.
Publicado: (2024)
A grand mimicker of pulmonary malignancy: The massive mediastinal intercostal nerve tumour
por: Syed H. Haq, et al.
Publicado: (2024)
por: Syed H. Haq, et al.
Publicado: (2024)
Fatal outcome in isolated Pauci‐immune pulmonary capillaritis: A case report
por: Zeinab El Mawla, et al.
Publicado: (2024)
por: Zeinab El Mawla, et al.
Publicado: (2024)
New Obstructive Sleep Apnoea Multi‐Night Diagnostic Devices. Is a Single Night of Measurement Now Considered Enough?
por: Thomas J. Altree, et al.
Publicado: (2026)
por: Thomas J. Altree, et al.
Publicado: (2026)
Ejemplares similares
-
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease (PuRe Duration Trial): A randomized controlled equivalence trial
por: Joshua A. Bishop, et al.
Publicado: (2024) -
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
por: John A. Mackintosh, et al.
Publicado: (2024) -
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial
por: Amy Ying Yu Tsui, et al.
Publicado: (2024) -
Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema
por: Marieke C. van der Molen, et al.
Publicado: (2024) -
Familial pulmonary fibrosis: Defining inherited fibrotic lung disease in the era of clinical genetic testing
por: Joanne L. Dickinson, et al.
Publicado: (2024)